Arjo ReNu sets the benchmark for medical device reprocessing in Australia
As Australia’s healthcare sector accelerates its response to sustainability and waste reduction, medical device reprocessing has moved from a niche concept to a strategic imperative. But as activity in the space grows, so does the need to distinguish established operators with proven results - from new entrants still finding their feet.
In Australia, one program stands out for its experience, scale and regulatory leadership. This is Arjo ReNu.
First to market. First to scale
In 2023, Arjo ReNu became Australia’s first Therapeutic Goods Administration (TGA)‑registered and ISO-accredited medical device reprocessing facility. At the time, there was no comparable regulated reprocessing operation in the local market.
Since then, Arjo ReNu has moved rapidly beyond early adoption to become the most established medical device reprocessing program with a TGA-registered facility in Australia - with broad, ongoing hospital engagement at scale with clear measurable outcomes; click here to find out why to consider Arjo ReNu.
Arjo ReNu operational scale, backed by data
Unlike pilot‑based initiatives, Arjo ReNu is delivering reprocessing at operational scale across the Australian healthcare system.
Since implementation, Arjo ReNu Australia has:
· Partnered with a growing network of hospitals nationwide
· Reprocessed a significant volume of single‑use medical devices
· Diverted substantial amounts of clinical waste from landfill
· Delivered measurable reductions in CO₂‑equivalent emissions
These outcomes reflect sustained, day‑to‑day hospital operations, not short‑term trials. Reprocessing is now embedded into routine workflows across both public and private healthcare providers, demonstrating the maturity and scalability of the program.
A fully integrated model
A key differentiator for Arjo ReNu is its end‑to‑end operating model, with Arjo retaining responsibility for the entire reprocessing cycle.
This includes on‑site collection infrastructure, staff education, transport, high‑level disinfection, quality control, lifecycle tracking, redistribution back to hospitals and sustainable disposal at the product's end‑of‑life.
All reprocessing is performed using a chemical‑free, water‑based high‑level disinfection process, relying solely on high‑temperature water and time. Devices can be safely reused up to 10 times, extending product life while maintaining regulatory compliance.
Advanced barcode technology tracks every device through its lifecycle, providing transparency, traceability and confidence for infection‑control teams.
Download the Arjo ReNu brochure:
Environmental benefits already being delivered
Whilst many sustainability programs remain future‑focused, Arjo ReNu is already delivering quantified environmental outcomes.
Participating hospitals receive free sustainability reports, detailing landfill diversion and emissions reductions aligned to internal ESG and sustainability reporting requirements.
Environmental optimisations extend beyond reprocessing itself, with:
- Recycled cardboard and paper used for repackaging
- Compostable collection bags
- Collections and deliveries integrated into existing logistics routes, ensuring no increase in transport‑related emissions
For hospitals under pressure to demonstrate tangible sustainability progress, these outcomes are already being realised.
Expanding capability with regulatory discipline
Arjo ReNu’s current Australian TGA registration covers Flowtron DVT garments, as well as AirPal and HoverMatt® lateral transfer mats. Further expansion is underway, guided by Arjo’s global reprocessing experience, with more than 120 product lines already validated internationally. Any local expansion follows a structured, regulator‑led process, ensuring patient safety and compliance remain paramount.
Raising the bar for circular healthcare
Arjo ReNu did not simply enter the Australian reprocessing market; it helped define it.
With the first TGA registration in Australia, a multi‑year operational head start, a substantial volume of devices already reprocessed, and a broad and growing hospital network, Arjo ReNu has established itself as the reference standard for medical device reprocessing in Australia.
As healthcare organisations shift from sustainability ambition to accountable action, programs with proven scale, regulatory credibility and measurable impact matter. In Australia, Arjo ReNu is already delivering on that promise.